Why the study?
Target mRNA specificity of SARS-CoV-2 NSP1 and how viral mRNAs escape NSP1-mediated degradation had not been clarified.
SARS-CoV-2 NSP1 acts as a translational switch and its effect on mRNA degradation depends on codon usage bias, explaining the prevalence of nonoptimal codons in coronavirus genomes.
NSP1's switch-like activity cautions against broad translation inhibitors in COVID-19; leaves open viral mRNA specificity mechanisms for targeted validation.
The nonstructural protein 1 (NSP1) of SARS-CoV-2 blocks the messenger RNA (mRNA) entry channel of the 40S ribosomal subunit, causing inhibition of translation initiation and subsequent degradation of host mRNAs. However, target mRNA specificity and how viral mRNAs escape NSP1-mediated degradation have not been clarified to date. Here we found that NSP1 acts as a translational switch capable of blocking or enhancing translation depending on how preinitiation complex, 43S-PIC, is recruited to the mRNA, whereas NSP1-mediated mRNA degradation mostly depends on codon usage bias. Thus, fast-translating mRNAs with optimal codon usage for human cells that preferentially recruit 43S-PIC by threading showed a dramatic sensitivity to NSP1. Translation of SARS-CoV-2 mRNAs escapes NSP1-mediated inhibition by a proper combination of suboptimal codon usage and slotting-prone 5' UTR. Thus, the prevalence of nonoptimal codons found in SARS-CoV-2 and other coronavirus genomes is favored by the distinctive effect that NSP1 plays on translation and mRNA stability.
No takes yet. Share an insight, caveat, or question.
Berlanga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: